FDA Inspection 804154 — Antares Pharma Inc.

Antares Pharma Inc. — FEI 3008877713

The FDA completed an inspection of Antares Pharma Inc. on Aug 20, 2012 in Ewing, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 20, 2012
Fiscal Year
2012
Product Type
Devices
Project Area
Compliance: Devices
Location
Ewing, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.